Inspire Medical Systems (INSP) Net Equity Issued and Repurchased (2018)

Inspire Medical Systems (INSP) reported Net Equity Issued and Repurchased of $69.8 million for Q4 2018, up 6978200.0% sequentially from $1000.0 in Q3 2018.

Inspire Medical Systems (INSP) Net Equity Issued and Repurchased (2018) Analysis & Trends

Inspire Medical Systems (INSP) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $69.8 million in Q4 2018.

  • For the quarter ending Q4 2018, Net Equity Issued and Repurchased changed N/A year-over-year to $69.8 million; the trailing twelve-month figure through Sep 2020 stood at $69.8 million (changed 0.0% YoY), and the FY2022 full-year result was $243.8 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased rose to $69.8 million in Q4 2018, from $1000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $69.8 million in Q4 2018 to a low of $1000.0 in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Inspire Medical Systems 1.46 Bn 1.17 Bn 176.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 69.78 Mn
Dec 31, 2018 69.78 Mn
Sep 30, 2018 1,000.00
Sep 30, 2018 1,000.00